Around 5.3 million people in England were given a National Institute for Health and Care Excellence recommended statin or ezetimibe by their GP to help reduce their cholesterol in 2023/24. Cholesterol can contribute to blood vessel blockages leading to heart attacks and strokes. This was an increase of 900,000 more receiving the treatment than in the previous year.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.
Networks can be open to all or available only to a closed group defined by the administrator.
Join or create a network here.
